Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes

Author(s): Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, et al.

Abstract

Objective: Latent autoimmune diabetes in adults (LADA) is often considered a slowly progressing subtype of type 1 diabetes, although the clinical picture more resembles type 2 diabetes. One way to improve classification is to study whether LADA shares genetic features with type 1 and/or type 2 diabetes.

Research design and methods: To accomplish this, we studied whether LADA shares variation in the HLA locus or INS VNTR and PTPN22 genes with type 1 diabetes or the TCF7L2 gene with type 2 diabetes in 361 LADA, 718 type 1 diabetic, and 1,676 type 2 diabetic patients, as well as 1,704 healthy control subjects from Sweden and Finland.

Results: LADA subjects showed, compared with type 2 diabetic patients, increased frequency of risk for the HLA-DQB1 *0201/*0302 genotype (27 vs. 6.9%; P < 1 x 10(-6)), with similar frequency as with type 1 diabetes (36%). In addition, LADA subjects showed higher frequencies of protective HLA-DQB1 *0602(3)/X than type 1 diabetic patients (8.1 vs. 3.2%, P = 0.003). The AA genotype of rs689, referring to the class I allele in the INS VNTR, as well as the CT/TT genotypes of rs2476601 in the PTPN22 gene, were increased both in type 1 diabetic (P = 3 x 10(-14) and P = 1 x 10(-10), respectively) and LADA (P = 0.001 and P = 0.002) subjects compared with control subjects. Notably, the frequency of the type 2 diabetes-associated CT/TT genotypes of rs7903146 in the TCF7L2 were increased in LADA subjects (52.8%; P = 0.03), to the same extent as in type 2 diabetic subjects (54.1%, P = 3 x 10(-7)), compared with control subjects (44.8%) and type 1 diabetic subjects (43.3%).

Conclusions: LADA shares genetic features with both type 1 (HLA, INS VNTR, and PTPN22) and type 2 (TCF7L2) diabetes, which justifies considering LADA as an admixture of the two major types of diabetes.

Similar Articles

Type 2 diabetes: principles of pathogenesis and therapy

Author(s): Stumvoll M, Goldstein BJ, van Haeften TW

Alternative therapies for type 2 diabetes

Author(s): Dey L, Attele AS, Yuan CS

Brussels, Belgium: International Diabetes Federation

Author(s): International Diabetes Federation

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Author(s): Wild S, Roglic G, Green A, Sicree R, King H

Prevalence of diabetes in Pakistan

Author(s): Shera AS, Jawad F, Maqsood A

Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53: 2504-2508

Author(s): Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, et al.

A narrative insight to maturity-onset diabetes of the young

Author(s): Kanwal SF, Fazal S, Muhammad Ismail, Nighat Naureen

[MODY type diabetes: overview and recent findings]

Author(s): Ben Khelifa S, Barboura I, Dandana A, Ferchichi S, Miled A

HLA-A, -B, and -DR associations in type 1 diabetes mellitus with onset after age forty

Author(s): Pittman WB, Acton RT, Barger BO, Bell DS, Go RC, et al.

Latent autoimmune diabetes in adults (LADA) should be less latent

Author(s): Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, et al.

Genetics of type 2 diabetes

Author(s): Owen KR, McCarthy MI

The emerging genetic architecture of type 2 diabetes

Author(s): Doria A, Patti ME, Kahn CR

Genome-wide association studies in type 2 diabetes

Author(s): McCarthy MI, Zeggini E

Type 2 diabetes: new genes, new understanding

Author(s): Prokopenko I, McCarthy MI, Lindgren CM

Type 2 Diabetes Genetics: Beyond GWAS

Author(s): Sanghera DK, Blackett PR

A genome-wide association study identifies novel risk loci for type 2 diabetes

Author(s): Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al.

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels

Author(s): Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF, et al.

A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants

Author(s): Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al.

A variant in CDKAL1 influences insulin response and risk of type 2 diabetes

Author(s): Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, et al.

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

Author(s): Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al.

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

Author(s): Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al.

Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci

Author(s): Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, et al.

Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes

Author(s): Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, et al.

Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

Author(s): Helgason A, Pálsson S, Thorleifsson G, Grant SF, Emilsson V, et al.

Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort

Author(s): van Vliet-Ostaptchouk JV, Shiri-Sverdlov R, Zhernakova A, Strengman E, van Haeften TW, et al.

Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study

Author(s): van Hoek M, Dehghan A, Witteman JC, van Duijn CM, Uitterlinden AG, et al.

Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus

Author(s): Maeda S, Tsukada S, Kanazawa A, Sekine A, Tsunoda T, et al.

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

Author(s): Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, et al.

Inflammatory markers and risk of developing type 2 diabetes in women

Author(s): Hu FB, Meigs JB, Li TY, Rifai N, Manson JE

Therapy with oral antidiabetic drugs: applied pharmacogenetics

Author(s): Holstein A, Seeringer A, Kovacs P

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

Author(s): Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, et al.

Pharmacogenetics of Anti-Diabetes Drugs

Author(s): Distefano JK, Watanabe RM

Pharmacogenetics of oral antidiabetic treatment

Author(s): Schroner Z, Javorsky M, Kozarova M, Tkac I

Genetic basis of type 2 diabetes mellitus: implications for therapy

Author(s): Wolford JK, Vozarova de Courten B